NeoPharm CO., LTD. (092730.KQ)

KRW 11960.0

(-0.33%)

Inventory Summary of NeoPharm CO., LTD.

NeoPharm CO., LTD.'s latest annual inventory in 2023 was 10.19 Billion KRW , up 16.53% from previous year.
NeoPharm CO., LTD.'s latest quarterly inventory in 2024 Q1 was 13.14 Billion KRW , up 28.91% from previous quarter.
NeoPharm CO., LTD. reported annual inventory of 8.74 Billion KRW in 2022, up 9.73% from previous year.
NeoPharm CO., LTD. reported annual inventory of 7.97 Billion KRW in 2021, down -1.44% from previous year.
NeoPharm CO., LTD. reported quarterly inventory of 13.14 Billion KRW for 2024 Q1, up 28.91% from previous quarter.
NeoPharm CO., LTD. reported quarterly inventory of 9.47 Billion KRW for 2023 Q1, up 8.24% from previous quarter.

Annual Inventory Chart of NeoPharm CO., LTD. (2023 - 2012)

Historical Annual Inventory of NeoPharm CO., LTD. (2023 - 2012)

Year	Inventory	Inventory Growth
2023	10.19 Billion KRW	16.53%
2022	8.74 Billion KRW	9.73%
2021	7.97 Billion KRW	-1.44%
2020	8.08 Billion KRW	38.51%
2019	5.84 Billion KRW	-14.67%
2018	6.84 Billion KRW	41.3%
2017	4.84 Billion KRW	16.53%
2016	4.15 Billion KRW	-2.09%
2015	4.24 Billion KRW	0.0%
2012	2.12 Billion KRW	0.0%

Year	Inventory	Inventory Growth
2024 Q2	13.01 Billion KRW	-0.96%
2024 Q1	13.14 Billion KRW	28.91%
2023 Q1	9.47 Billion KRW	8.24%
2023 FY	10.19 Billion KRW	16.53%
2023 Q4	10.19 Billion KRW	-4.72%
2023 Q3	10.7 Billion KRW	22.12%
2023 Q2	8.76 Billion KRW	-7.48%
2022 Q3	10.3 Billion KRW	-5.57%
2022 Q1	9.51 Billion KRW	19.35%
2022 FY	8.74 Billion KRW	9.73%
2022 Q4	8.74 Billion KRW	-15.11%
2022 Q2	10.91 Billion KRW	14.7%
2021 Q4	7.97 Billion KRW	-10.22%
2021 Q1	9.09 Billion KRW	12.41%
2021 FY	7.97 Billion KRW	-1.44%
2021 Q2	9.38 Billion KRW	3.17%
2021 Q3	8.88 Billion KRW	-5.34%
2020 FY	8.08 Billion KRW	38.51%
2020 Q4	8.08 Billion KRW	-3.26%
2020 Q2	9.08 Billion KRW	11.04%
2020 Q3	8.36 Billion KRW	-7.95%
2020 Q1	8.18 Billion KRW	40.07%
2019 Q3	7.31 Billion KRW	-1.28%
2019 Q1	8.3 Billion KRW	21.31%
2019 FY	5.84 Billion KRW	-14.67%
2019 Q4	5.84 Billion KRW	-20.17%
2019 Q2	7.41 Billion KRW	-10.74%
2018 Q2	5.15 Billion KRW	-13.44%
2018 FY	6.84 Billion KRW	41.3%
2018 Q1	5.95 Billion KRW	22.95%
2018 Q4	6.84 Billion KRW	18.76%
2018 Q3	5.76 Billion KRW	11.8%
2017 Q1	4.64 Billion KRW	11.71%
2017 FY	4.84 Billion KRW	16.53%
2017 Q4	4.84 Billion KRW	8.59%
2017 Q3	4.46 Billion KRW	4.0%
2017 Q2	4.28 Billion KRW	-7.63%
2016 Q2	3.52 Billion KRW	0.0%
2016 Q4	4.15 Billion KRW	29.95%
2016 Q3	3.19 Billion KRW	-9.23%
2016 Q1	- KRW	-100.0%
2016 FY	4.15 Billion KRW	-2.09%
2015 Q4	4.24 Billion KRW	0.0%
2015 FY	4.24 Billion KRW	0.0%
2013 Q2	2.6 Billion KRW	12.45%
2013 Q3	2.52 Billion KRW	-2.99%
2013 Q1	2.31 Billion KRW	8.94%
2012 Q4	2.12 Billion KRW	0.0%
2012 FY	2.12 Billion KRW	0.0%

Peer Inventory Comparison of NeoPharm CO., LTD.

Name	Inventory	Inventory Difference
Kolmar BNH Co., Ltd.	90.5 Billion KRW	88.735%